« Back to the previous page

Also available in: Nederlands

Buyer for OTC manufacturer in Europe

Company to buy

  • Size: mid-sized or large company
  • Revenue: 2-20 M EUR
  • Location of the target: Europe
  • Reason for acquisition: An Irish based healthcare company would like to growth by acquiring other companies in Europe. 
  • #CFIE PHB031


Overview of this of this buyer for pharmaceutical OTC manufacturer unit wanted 

The buyer would like to acquire OTC manufacturer unit operating on pharmaceutical market in Europe. Preferably a company that has a potential growth and own pharma branded products. 


Profile (strategy) of this OTC manufacturer buyer unit

A European healthcare company that focuses on prescription and OTC market segment. The company was incorporated 20 years ago and today plays a significant role in a pharmaceutical market. Among company strategic goal is to license and rebrand products in new and developing markets.

Their products are already marketed in Australia, New Zealand and Europe: Spain, Italy, France, Czech Republic, Slovakia, Netherlands, and Portugal.

The company’s main pharma products are:

Uniflu

Exputex

Peracetamol

Nasosal


Contact us to get details about this buyer for OTC manufacturer in Europe


Activities and products of the target OTC manufacturer unit

The company is looking for a well-established, mid-size company, operating in the generics marketing and sales industry. The buyer would prefer if the target had a presence in Rx as well as OTC segment. 

The buyer would like to acquire OTC manufacturer unit operating on pharmaceutical market in Europe. Preferably mature brands with further growth potential which markets their products and operates in the prescription and OTC market segments. 

The yearly revenue should be between 2-20 million euros, comply with all necessary GMP documents and would help to bring added value in terms of market share, strong branded products and expertise. 


Highlights of this OTC manufacturer buyer 

  • A European healthcare company that focuses on prescription and OTC market segment. 
  • Would like to acquire pharmaceutical OTC manufacturer unit with branded products in Europe. 
  • The target should have the revenue between (2– 20 million eur).


Information on this pharma laboratory company 

Feel free to contact us for more information regarding this OTC manufacturer buyer wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale.


Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company, we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual, please explain as much as possible about your personal background, strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.